Nuclear Medicine Isotopes Market, Global Outlook and Forecast 2023-2028

Report ID: 1134700 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Nuclear Medicine Isotopes Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Nuclear Medicine Isotopes Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Nuclear Medicine Isotopes Overall Market Size
    2.1 Global Nuclear Medicine Isotopes Market Size: 2021 VS 2028
    2.2 Global Nuclear Medicine Isotopes Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Nuclear Medicine Isotopes Players in Global Market
    3.2 Top Global Nuclear Medicine Isotopes Companies Ranked by Revenue
    3.3 Global Nuclear Medicine Isotopes Revenue by Companies
    3.4 Top 3 and Top 5 Nuclear Medicine Isotopes Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Nuclear Medicine Isotopes Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Nuclear Medicine Isotopes Players in Global Market
        3.6.1 List of Global Tier 1 Nuclear Medicine Isotopes Companies
        3.6.2 List of Global Tier 2 and Tier 3 Nuclear Medicine Isotopes Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Nuclear Medicine Isotopes Market Size Markets, 2021 & 2028
        4.1.2 Stable Isotopes
        4.1.3 Radioisotopes
    4.2 By Type - Global Nuclear Medicine Isotopes Revenue & Forecasts
        4.2.1 By Type - Global Nuclear Medicine Isotopes Revenue, 2017-2022
        4.2.2 By Type - Global Nuclear Medicine Isotopes Revenue, 2023-2028
        4.2.3 By Type - Global Nuclear Medicine Isotopes Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Nuclear Medicine Isotopes Market Size, 2021 & 2028
        5.1.2 Nuclear Therapy
        5.1.3 Equipment Radioactive Source
        5.1.4 Diagnosis
    5.2 By Application - Global Nuclear Medicine Isotopes Revenue & Forecasts
        5.2.1 By Application - Global Nuclear Medicine Isotopes Revenue, 2017-2022
        5.2.2 By Application - Global Nuclear Medicine Isotopes Revenue, 2023-2028
        5.2.3 By Application - Global Nuclear Medicine Isotopes Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Nuclear Medicine Isotopes Market Size, 2021 & 2028
    6.2 By Region - Global Nuclear Medicine Isotopes Revenue & Forecasts
        6.2.1 By Region - Global Nuclear Medicine Isotopes Revenue, 2017-2022
        6.2.2 By Region - Global Nuclear Medicine Isotopes Revenue, 2023-2028
        6.2.3 By Region - Global Nuclear Medicine Isotopes Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Nuclear Medicine Isotopes Revenue, 2017-2028
        6.3.2 US Nuclear Medicine Isotopes Market Size, 2017-2028
        6.3.3 Canada Nuclear Medicine Isotopes Market Size, 2017-2028
        6.3.4 Mexico Nuclear Medicine Isotopes Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Nuclear Medicine Isotopes Revenue, 2017-2028
        6.4.2 Germany Nuclear Medicine Isotopes Market Size, 2017-2028
        6.4.3 France Nuclear Medicine Isotopes Market Size, 2017-2028
        6.4.4 U.K. Nuclear Medicine Isotopes Market Size, 2017-2028
        6.4.5 Italy Nuclear Medicine Isotopes Market Size, 2017-2028
        6.4.6 Russia Nuclear Medicine Isotopes Market Size, 2017-2028
        6.4.7 Nordic Countries Nuclear Medicine Isotopes Market Size, 2017-2028
        6.4.8 Benelux Nuclear Medicine Isotopes Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Nuclear Medicine Isotopes Revenue, 2017-2028
        6.5.2 China Nuclear Medicine Isotopes Market Size, 2017-2028
        6.5.3 Japan Nuclear Medicine Isotopes Market Size, 2017-2028
        6.5.4 South Korea Nuclear Medicine Isotopes Market Size, 2017-2028
        6.5.5 Southeast Asia Nuclear Medicine Isotopes Market Size, 2017-2028
        6.5.6 India Nuclear Medicine Isotopes Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Nuclear Medicine Isotopes Revenue, 2017-2028
        6.6.2 Brazil Nuclear Medicine Isotopes Market Size, 2017-2028
        6.6.3 Argentina Nuclear Medicine Isotopes Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Nuclear Medicine Isotopes Revenue, 2017-2028
        6.7.2 Turkey Nuclear Medicine Isotopes Market Size, 2017-2028
        6.7.3 Israel Nuclear Medicine Isotopes Market Size, 2017-2028
        6.7.4 Saudi Arabia Nuclear Medicine Isotopes Market Size, 2017-2028
        6.7.5 UAE Nuclear Medicine Isotopes Market Size, 2017-2028
7 Players Profiles
    7.1 NRG
        7.1.1 NRG Corporate Summary
        7.1.2 NRG Business Overview
        7.1.3 NRG Nuclear Medicine Isotopes Major Product Offerings
        7.1.4 NRG Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.1.5 NRG Key News
    7.2 NTP Radioisotopes
        7.2.1 NTP Radioisotopes Corporate Summary
        7.2.2 NTP Radioisotopes Business Overview
        7.2.3 NTP Radioisotopes Nuclear Medicine Isotopes Major Product Offerings
        7.2.4 NTP Radioisotopes Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.2.5 NTP Radioisotopes Key News
    7.3 JSC Isotope
        7.3.1 JSC Isotope Corporate Summary
        7.3.2 JSC Isotope Business Overview
        7.3.3 JSC Isotope Nuclear Medicine Isotopes Major Product Offerings
        7.3.4 JSC Isotope Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.3.5 JSC Isotope Key News
    7.4 ANSTO
        7.4.1 ANSTO Corporate Summary
        7.4.2 ANSTO Business Overview
        7.4.3 ANSTO Nuclear Medicine Isotopes Major Product Offerings
        7.4.4 ANSTO Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.4.5 ANSTO Key News
    7.5 IRE
        7.5.1 IRE Corporate Summary
        7.5.2 IRE Business Overview
        7.5.3 IRE Nuclear Medicine Isotopes Major Product Offerings
        7.5.4 IRE Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.5.5 IRE Key News
    7.6 Nordion
        7.6.1 Nordion Corporate Summary
        7.6.2 Nordion Business Overview
        7.6.3 Nordion Nuclear Medicine Isotopes Major Product Offerings
        7.6.4 Nordion Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.6.5 Nordion Key News
    7.7 Curium Pharma
        7.7.1 Curium Pharma Corporate Summary
        7.7.2 Curium Pharma Business Overview
        7.7.3 Curium Pharma Nuclear Medicine Isotopes Major Product Offerings
        7.7.4 Curium Pharma Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.7.5 Curium Pharma Key News
    7.8 Cambridge Isotope Laboratories
        7.8.1 Cambridge Isotope Laboratories Corporate Summary
        7.8.2 Cambridge Isotope Laboratories Business Overview
        7.8.3 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Major Product Offerings
        7.8.4 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.8.5 Cambridge Isotope Laboratories Key News
    7.9 Eckert & Ziegler Strahlen
        7.9.1 Eckert & Ziegler Strahlen Corporate Summary
        7.9.2 Eckert & Ziegler Strahlen Business Overview
        7.9.3 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Major Product Offerings
        7.9.4 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.9.5 Eckert & Ziegler Strahlen Key News
    7.10 Polatom
        7.10.1 Polatom Corporate Summary
        7.10.2 Polatom Business Overview
        7.10.3 Polatom Nuclear Medicine Isotopes Major Product Offerings
        7.10.4 Polatom Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.10.5 Polatom Key News
    7.11 Center of Molecular Research
        7.11.1 Center of Molecular Research Corporate Summary
        7.11.2 Center of Molecular Research Business Overview
        7.11.3 Center of Molecular Research Nuclear Medicine Isotopes Major Product Offerings
        7.11.4 Center of Molecular Research Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.11.5 Center of Molecular Research Key News
    7.12 China National Nuclear Corporation
        7.12.1 China National Nuclear Corporation Corporate Summary
        7.12.2 China National Nuclear Corporation Business Overview
        7.12.3 China National Nuclear Corporation Nuclear Medicine Isotopes Major Product Offerings
        7.12.4 China National Nuclear Corporation Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.12.5 China National Nuclear Corporation Key News
    7.13 Urenco
        7.13.1 Urenco Corporate Summary
        7.13.2 Urenco Business Overview
        7.13.3 Urenco Nuclear Medicine Isotopes Major Product Offerings
        7.13.4 Urenco Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.13.5 Urenco Key News
    7.14 LANL
        7.14.1 LANL Corporate Summary
        7.14.2 LANL Business Overview
        7.14.3 LANL Nuclear Medicine Isotopes Major Product Offerings
        7.14.4 LANL Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.14.5 LANL Key News
    7.15 Shanghai Engineering Research Center
        7.15.1 Shanghai Engineering Research Center Corporate Summary
        7.15.2 Shanghai Engineering Research Center Business Overview
        7.15.3 Shanghai Engineering Research Center Nuclear Medicine Isotopes Major Product Offerings
        7.15.4 Shanghai Engineering Research Center Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.15.5 Shanghai Engineering Research Center Key News
    7.16 IDB Holland
        7.16.1 IDB Holland Corporate Summary
        7.16.2 IDB Holland Business Overview
        7.16.3 IDB Holland Nuclear Medicine Isotopes Major Product Offerings
        7.16.4 IDB Holland Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.16.5 IDB Holland Key News
    7.17 NHTC
        7.17.1 NHTC Corporate Summary
        7.17.2 NHTC Business Overview
        7.17.3 NHTC Nuclear Medicine Isotopes Major Product Offerings
        7.17.4 NHTC Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.17.5 NHTC Key News
    7.18 Linde
        7.18.1 Linde Corporate Summary
        7.18.2 Linde Business Overview
        7.18.3 Linde Nuclear Medicine Isotopes Major Product Offerings
        7.18.4 Linde Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.18.5 Linde Key News
    7.19 ORNL
        7.19.1 ORNL Corporate Summary
        7.19.2 ORNL Business Overview
        7.19.3 ORNL Nuclear Medicine Isotopes Major Product Offerings
        7.19.4 ORNL Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.19.5 ORNL Key News
    7.20 SI Science
        7.20.1 SI Science Corporate Summary
        7.20.2 SI Science Business Overview
        7.20.3 SI Science Nuclear Medicine Isotopes Major Product Offerings
        7.20.4 SI Science Nuclear Medicine Isotopes Revenue in Global Market (2017-2022)
        7.20.5 SI Science Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Nuclear Medicine Isotopes Market Opportunities & Trends in Global Market
    Table 2. Nuclear Medicine Isotopes Market Drivers in Global Market
    Table 3. Nuclear Medicine Isotopes Market Restraints in Global Market
    Table 4. Key Players of Nuclear Medicine Isotopes in Global Market
    Table 5. Top Nuclear Medicine Isotopes Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Nuclear Medicine Isotopes Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Nuclear Medicine Isotopes Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Nuclear Medicine Isotopes Product Type
    Table 9. List of Global Tier 1 Nuclear Medicine Isotopes Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Nuclear Medicine Isotopes Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Nuclear Medicine Isotopes Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Nuclear Medicine Isotopes Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Nuclear Medicine Isotopes Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Nuclear Medicine Isotopes Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Nuclear Medicine Isotopes Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Nuclear Medicine Isotopes Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Nuclear Medicine Isotopes Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Nuclear Medicine Isotopes Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Nuclear Medicine Isotopes Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Nuclear Medicine Isotopes Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Nuclear Medicine Isotopes Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Nuclear Medicine Isotopes Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Nuclear Medicine Isotopes Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Nuclear Medicine Isotopes Revenue, (US$, Mn), 2023-2028
    Table 30. NRG Corporate Summary
    Table 31. NRG Nuclear Medicine Isotopes Product Offerings
    Table 32. NRG Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 33. NTP Radioisotopes Corporate Summary
    Table 34. NTP Radioisotopes Nuclear Medicine Isotopes Product Offerings
    Table 35. NTP Radioisotopes Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 36. JSC Isotope Corporate Summary
    Table 37. JSC Isotope Nuclear Medicine Isotopes Product Offerings
    Table 38. JSC Isotope Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 39. ANSTO Corporate Summary
    Table 40. ANSTO Nuclear Medicine Isotopes Product Offerings
    Table 41. ANSTO Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 42. IRE Corporate Summary
    Table 43. IRE Nuclear Medicine Isotopes Product Offerings
    Table 44. IRE Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 45. Nordion Corporate Summary
    Table 46. Nordion Nuclear Medicine Isotopes Product Offerings
    Table 47. Nordion Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 48. Curium Pharma Corporate Summary
    Table 49. Curium Pharma Nuclear Medicine Isotopes Product Offerings
    Table 50. Curium Pharma Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 51. Cambridge Isotope Laboratories Corporate Summary
    Table 52. Cambridge Isotope Laboratories Nuclear Medicine Isotopes Product Offerings
    Table 53. Cambridge Isotope Laboratories Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 54. Eckert & Ziegler Strahlen Corporate Summary
    Table 55. Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Product Offerings
    Table 56. Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 57. Polatom Corporate Summary
    Table 58. Polatom Nuclear Medicine Isotopes Product Offerings
    Table 59. Polatom Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 60. Center of Molecular Research Corporate Summary
    Table 61. Center of Molecular Research Nuclear Medicine Isotopes Product Offerings
    Table 62. Center of Molecular Research Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 63. China National Nuclear Corporation Corporate Summary
    Table 64. China National Nuclear Corporation Nuclear Medicine Isotopes Product Offerings
    Table 65. China National Nuclear Corporation Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 66. Urenco Corporate Summary
    Table 67. Urenco Nuclear Medicine Isotopes Product Offerings
    Table 68. Urenco Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 69. LANL Corporate Summary
    Table 70. LANL Nuclear Medicine Isotopes Product Offerings
    Table 71. LANL Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 72. Shanghai Engineering Research Center Corporate Summary
    Table 73. Shanghai Engineering Research Center Nuclear Medicine Isotopes Product Offerings
    Table 74. Shanghai Engineering Research Center Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 75. IDB Holland Corporate Summary
    Table 76. IDB Holland Nuclear Medicine Isotopes Product Offerings
    Table 77. IDB Holland Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 78. NHTC Corporate Summary
    Table 79. NHTC Nuclear Medicine Isotopes Product Offerings
    Table 80. NHTC Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 81. Linde Corporate Summary
    Table 82. Linde Nuclear Medicine Isotopes Product Offerings
    Table 83. Linde Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 84. ORNL Corporate Summary
    Table 85. ORNL Nuclear Medicine Isotopes Product Offerings
    Table 86. ORNL Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
    Table 87. SI Science Corporate Summary
    Table 88. SI Science Nuclear Medicine Isotopes Product Offerings
    Table 89. SI Science Nuclear Medicine Isotopes Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Nuclear Medicine Isotopes Segment by Type in 2021
    Figure 2. Nuclear Medicine Isotopes Segment by Application in 2021
    Figure 3. Global Nuclear Medicine Isotopes Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Nuclear Medicine Isotopes Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Nuclear Medicine Isotopes Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Nuclear Medicine Isotopes Revenue in 2021
    Figure 8. By Type - Global Nuclear Medicine Isotopes Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Nuclear Medicine Isotopes Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Nuclear Medicine Isotopes Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Nuclear Medicine Isotopes Revenue Market Share, 2017-2028
    Figure 12. US Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Nuclear Medicine Isotopes Revenue Market Share, 2017-2028
    Figure 16. Germany Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 17. France Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Nuclear Medicine Isotopes Revenue Market Share, 2017-2028
    Figure 24. China Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 28. India Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Nuclear Medicine Isotopes Revenue Market Share, 2017-2028
    Figure 30. Brazil Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Nuclear Medicine Isotopes Revenue Market Share, 2017-2028
    Figure 33. Turkey Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Nuclear Medicine Isotopes Revenue, (US$, Mn), 2017-2028
    Figure 37. NRG Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. NTP Radioisotopes Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. JSC Isotope Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. ANSTO Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. IRE Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Nordion Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Curium Pharma Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Cambridge Isotope Laboratories Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Polatom Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Center of Molecular Research Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. China National Nuclear Corporation Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Urenco Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. LANL Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Shanghai Engineering Research Center Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. IDB Holland Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. NHTC Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Linde Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. ORNL Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 56. SI Science Nuclear Medicine Isotopes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
114
Frequently Asked Questions
Nuclear Medicine Isotopes Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Nuclear Medicine Isotopes Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Nuclear Medicine Isotopes Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports